technology

drug, herbal, medicine, patent, pharma, technology

Conduit Pharmaceuticals Receives Additional Patent Approval for Lead Autoimmune Disease Asset

/

Conduit Pharmaceuticals Inc. (NASDAQ: CDT), a biopharmaceutical company focused on developing treatments for autoimmune and inflammatory diseases, announced today that it has received further patent approval for its lead therapeutic asset targeting autoimmune conditions. The newly granted patent strengthens the company’s intellectual property portfolio and provides added protection for its innovative approach to treating autoimmune […]

diabetes, drug, herbal, medicine, patent, pharma, technology, WHO

WHO and Medicines Patent Pool Support Nigerian Innovation in Health Diagnostic

/

In a landmark step towards strengthening healthcare innovation in Africa, the World Health Organization (WHO) and the Medicines Patent Pool (MPP) have announced strategic support for Nigerian-led advancements in health diagnostics. This collaboration is aimed at fostering local innovation, improving access to affordable diagnostic tools, and enhancing the country’s capacity to respond to pressing public

Uncategorized, agriculture, machine, patent, technology, water harvesting

Patent for New Technology ‘Polymer Based Pulley-Driven Centrifugal Pump’

/

Dr. A Ramarao, the Additional Project Coordinator for Samagra Shiksha, has been granted a Patent for 20-years by the Government of India for his groundbreaking innovation of the ‘Polymer Pulley-Driven Centrifugal Pump’. This patent was granted on March 4, 2025, and represents a major technological advancement in the field of mechanical engineering and in field

pharma, battle, dispute, drug, infringement, medicine, patent, technology, Uncategorized

Madras High Court ruled in favor of Pfizer’s patent rights

/

In a recent global patent disputes, the Madras High Court has pronounced a ruling concerning the ongoing patent dispute in the United States involving Pfizer’s drug, VYNDAMAX (also known as TAFAMIDIS), which is used to treat a rare heart condition called transthyretin amyloid cardiomyopathy (ATTR-CM). The case is in focus due to the high stakes

Uncategorized, patent, solar, technology

NIT Rourkela secure Patent in New Solar Technology

/

National Institute of Technology (NIT) Rourkela has secured a low-cost technology patent which is designed to optimize the energy output from solar panels. This groundbreaking technology is a revolution in the field of solar power generation by improving efficiency, reducing the effective costs, and increasing the overall viability of solar energy as a sustainable power

Uncategorized, patent, pharma, planting, technology

Delhi High Court upheld Controller’s decision under section 10(4)

/

The Delhi High Court’s decision highlights the importance of fulfilling the detailed disclosure requirements under the Patents Act 1970, particularly in terms of the scope of the claims made in a patent application. The ruling on the patent application by the Regents of the University of California relates to a recombinant Salmonella microorganism-based live vaccine

anti-ageing, drug, medicine, patent, pharma, technology, Uncategorized

Pharma consultant Agrawal filed patent for new anti-ageing drug

/

Sanjay Agrawal, a scientific advisor for the US-based Alkomex GBN Pharma Group and an Ahmedabad-based researcher, has filed for a patent for an anti-aging drug formulation aimed at combating aging at the cellular level. The formulation is designed to address the underlying biological processes of aging, potentially offering a groundbreaking approach to age-related issues. The

solar, battle, dispute, infringement, patent, technology, Uncategorized

Longi sues JinkoSolar for infringement of new patent technology

/

Longi, has filed lawsuits against JinkoSolar for their patent infringement, both the companies are leading players in the solar industry. The legal actions have been initiated in both countries China and the United States.In China, Longi has filed the lawsuit at the Jinan Intermediate People’s Court in Shandong and requested an immediate halt to the

Scroll to Top